CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Travere Therapeutics Insider Sold Shares Worth $2,785,021, According to a Recent SEC Filing

Neutral
AI Analysis

Summary

Travere Therapeutics insider sold shares worth $2,785,021 according to recent SEC filing.

Importance:1/10
Sentiment:
0.00
insider_sellingSEC_filing
Related Companies

Read the original article

Published by yahoo_finance on September 18, 2026 7:46 AM

Read Original